Neuropsychopharmacology - Table of Contents alert Volume 36 Issue 12

TABLE OF CONTENTS Volume 36, Issue 12 (November 2011) In this issue Commentary Perspective Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement A personalized experience in clinical trial publishing. Network with Pharma Solutions on Linked In. Our group connects key decision makers in clinical trial publishing, including lead investigators, pharmaceutical companies, and medical communication agencies. Join in discussions and hot topics shaping the industry.   Commentary Top Reelin, a Marker of Stress Resilience in Depression and Psychosis S Hossein Fatemi Neuropsychopharmacology 2011 36: 2371-2372; 10.1038/npp.2011.169 Full Text Perspective Top Treating Mouse Models of Huntington Disease Sara J Tallaksen-Greene and Roger L Albin Neuropsychopharmacology 2011 36: 2373-2374; advance online publication, August 3, 2011; 10.1038/npp.2011.158 Full Text Review Top Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology Heath D Schmidt, Richard C Shelton and Ronald S Duman Neuropsychopharmacology 2011 36: 2375-2394; advance online publication, August 3, 2011; 10.1038/npp.2011.151 Abstract | Full Text Original Articles Top Overexpression of Reelin Prevents the Manifestation of Behavioral Phenotypes Related to Schizophrenia and Bipolar Disorder Cátia M Teixeira, Eduardo D Martín, Ignasi Sahún, Nuria Masachs, Lluís Pujadas, André Corvelo, Carles Bosch, Daniela Rossi, Albert Martinez, Rafael Maldonado, Mara Dierssen and Eduardo Soriano Neuropsychopharmacology 2011 36: 2395-2405; advance online publication, August 3, 2011; 10.1038/npp.2011.153 Abstract | Full Text Combined Treatment with the Mood Stabilizers Lithium and Valproate Produces Multiple Beneficial Effects in Transgenic Mouse Models of Huntington's Disease Chi-Tso Chiu, Guangping Liu, Peter Leeds and De-Maw Chuang Neuropsychopharmacology 2011 36: 2406-2421; advance online publication, July 27, 2011; 10.1038/npp.2011.128 Abstract | Full Text A Genomewide Linkage Scan of Cocaine Dependence and Major Depressive Episode in Two Populations Bao-Zhu Yang, Shizhong Han, Henry R Kranzler, Lindsay A Farrer and Joel Gelernter Neuropsychopharmacology 2011 36: 2422-2430; advance online publication, August 17, 2011; 10.1038/npp.2011.122 Abstract | Full Text Neuroimaging Evidence of Altered Fronto-Cortical and Striatal Function after Prolonged Cocaine Self-Administration in the Rat Alessandro Gozzi, Michela Tessari, Lisa Dacome, Federica Agosta, Stefano Lepore, Anna Lanzoni, Patrizia Cristofori, Emilio M Pich, Mauro Corsi and Angelo Bifone Neuropsychopharmacology 2011 36: 2431-2440; advance online publication, July 20, 2011; 10.1038/npp.2011.129 Abstract | Full Text Impaired Formation of Stimulus–Response, But Not Action–Outcome, Associations in Rats with Methamphetamine-Induced Neurotoxicity Jong-Hyun Son, Christine Latimer and Kristen A Keefe Neuropsychopharmacology 2011 36: 2441-2451; advance online publication, July 20, 2011; 10.1038/npp.2011.131 Abstract | Full Text The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis Jonas Hannestad, Nicole DellaGioia and Michael Bloch Neuropsychopharmacology 2011 36: 2452-2459; advance online publication, July 27, 2011; 10.1038/npp.2011.132 Abstract | Full Text Antidepressant and Proneurogenic Influence of Environmental Enrichment in Mice: Protective Effects vs Recovery María Llorens-Martín, Gonzalo S Tejeda and José L Trejo Neuropsychopharmacology 2011 36: 2460-2468; advance online publication, July 27, 2011; 10.1038/npp.2011.134 Abstract | Full Text Acute Phenylalanine/Tyrosine Depletion Reduces Motivation to Smoke Cigarettes Across Stages of Addiction Viswanath V Venugopalan, Kevin F Casey, Caitlin O'Hara, Jennifer O'Loughlin, Chawki Benkelfat, Lesley K Fellows and Marco Leyton Neuropsychopharmacology 2011 36: 2469-2476; advance online publication, July 20, 2011; 10.1038/npp.2011.135 Abstract | Full Text Transient Inactivation of the Neonatal Ventral Hippocampus Permanently Disrupts the Mesolimbic Regulation of Prefrontal Cholinergic Transmission: Implications for Schizophrenia Julie M Brooks, Martin Sarter and John P Bruno Neuropsychopharmacology 2011 36: 2477-2487; advance online publication, August 3, 2011; 10.1038/npp.2011.136 Abstract | Full Text Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm: Peripheral vs Central Administration Luke W Ayers, Galen Missig, Jay Schulkin and Jeffrey B Rosen Neuropsychopharmacology 2011 36: 2488-2497; advance online publication, July 27, 2011; 10.1038/npp.2011.138 Abstract | Full Text Acute Nicotine-Induced Tachyphylaxis Is Differentially Manifest in the Limbic System Yantao Zuo, Hanbing Lu, D Bruce Vaupel, Yi Zhang, Svetlana I Chefer, William R Rea, Anna V Moore, Yihong Yang and Elliot A Stein Neuropsychopharmacology 2011 36: 2498-2512; advance online publication, July 27, 2011; 10.1038/npp.2011.139 Abstract | Full Text Synaptic and Morphological Neuroadaptations in the Putamen Associated with Long-Term, Relapsing Alcohol Drinking in Primates Verginia C Cuzon Carlson, Gail K Seabold, Christa M Helms, Natasha Garg, Misa Odagiri, Andrew R Rau, James Daunais, Veronica A Alvarez, David M Lovinger and Kathleen A Grant Neuropsychopharmacology 2011 36: 2513-2528; advance online publication, July 27, 2011; 10.1038/npp.2011.140 Abstract | Full Text AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder Ruud van Winkel, Nico J M van Beveren, Claudia Simons, the Genetic Risk and Outcome of Psychosis (GROUP) Investigators and Genetic Risk and Outcome of Psychosis (GROUP) Investigators Neuropsychopharmacology 2011 36: 2529-2537; advance online publication, July 20, 2011; 10.1038/npp.2011.141 Abstract | Full Text Severe Serotonin Depletion after Conditional Deletion of the Vesicular Monoamine Transporter 2 Gene in Serotonin Neurons: Neural and Behavioral Consequences Nicolas Narboux-Nême, Corinne Sagné, Stephane Doly, Silvina L Diaz, Cédric B P Martin, Gaelle Angenard, Marie-Pascale Martres, Bruno Giros, Michel Hamon, Laurence Lanfumey, Patricia Gaspar and Raymond Mongeau Neuropsychopharmacology 2011 36: 2538-2550; advance online publication, August 3, 2011; 10.1038/npp.2011.142 Abstract | Full Text Cocaine-Induced Adaptations in Cellular Redox Balance Contributes to Enduring Behavioral Plasticity Joachim D Uys, Lori Knackstedt, Phelipe Hurt, Kenneth D Tew, Yefim Manevich, Steven Hutchens, Danyelle M Townsend and Peter W Kalivas Neuropsychopharmacology 2011 36: 2551-2560; advance online publication, July 27, 2011; 10.1038/npp.2011.143 Abstract | Full Text Haloperidol Regulates the State of Phosphorylation of Ribosomal Protein S6 via Activation of PKA and Phosphorylation of DARPP-32 Emmanuel Valjent, Jesus Bertran-Gonzalez, Heather Bowling, Sébastien Lopez, Emanuela Santini, Miriam Matamales, Alessandra Bonito-Oliva, Denis Hervé, Charles Hoeffer, Eric Klann, Jean-Antoine Girault and Gilberto Fisone Neuropsychopharmacology 2011 36: 2561-2570; advance online publication, August 3, 2011; 10.1038/npp.2011.144 Abstract | Full Text Laminin-β1 Impairs Spatial Learning through Inhibition of ERK/MAPK and SGK1 Signaling Ying C Yang, Yun L Ma, Wen T Liu and Eminy HY Lee Neuropsychopharmacology 2011 36: 2571-2586; advance online publication, August 17, 2011; 10.1038/npp.2011.148 Abstract | Full Text Advertisement Submit your best research in neuroscience, pharmacology, and psychiatry Today! Neuropsychopharmacology, the official publication of the American College of Neuropsychopharmacology (ACNP), focuses on clinical and basic science contributions that advance the understanding of brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. To view the complete Guide to Authors and full benefits of publishing with Neuropsychopharmacology please visit http://www.nature.com/npp/for_authors.html   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.